Results 11 to 20 of about 7,523 (176)
Background. Chronic heart failure is the main critical illness and cause of death in the later stages of cardiovascular disease, and it is one of the two major challenges in the field of cardiovascular research. The clinical application of traditional Chinese medicine in the prevention and treatment of chronic heart failure has been relatively common ...
Qianyan Wu +6 more
wiley +1 more source
Efficacy and Safety Combined with Conventional and Western Medicine Treatments on Coronary Heart Disease Complicated with Heart Failure:a Systematic Review [PDF]
BackgroundAnti-atherosclerotic and anti-heart failure therapies are the key to the treatment of coronary heart disease (CHD) , a common cardiovascular disease.
WANG Tianyuan, WANG Yanbo, FENG Shuo, HU Jing, ZHANG Huina, WANG Hong, LI Bo
core +1 more source
Highlights The GRK2 level elevated not only in the myocardium of diabetic mice with early stage of diabetic cardiomyopathy but also in the peripheral blood mononuclear cells of type 2 diabetic patients with the early stage of diabetic cardiomyopathy. The study findings suggested that the GRK2 was a potential biomarker for early diabetic cardiomyopathy.
Shuiqing Lai +6 more
wiley +1 more source
Heart Failure with Mid-range Ejection Fraction——a Comprehension of the Disease [PDF]
Heart failure is the final main battlefield of various cardiovascular diseases with huge harm, which can cause all kinds of arrhythmias and even sudden cardiac death. The 2016 ESC guidelines formally define heart failure with mid-range ejection fraction (
RUAN Zheng, HUANG Jianyu, JIANG Wencai, CHEN Meixiang, QIN Changyu, XU Lin
core +1 more source
Reliability and Validity of the Chinese Version of the Partners in Health Scale in Patients with Chronic Heart Failure [PDF]
BackgroundChronic heart failure (CHF) is a common cardiovascular disease. Improving the self-management ability of CHF patients will contribute to quality of life improvement and reduction of rehospitalization and mortality rates. The Partners in Health (
WANG Xiaonan, JIANG Ying, KANG Xiaofeng, JI Shiming, ZHANG Jian
core +1 more source
个体化护理对小儿肺炎合并心力衰竭患者的应用效果及心功能改善情况分析
目的:研究对小儿肺炎合并心力衰竭患儿开展个体化护理干预的价值。方法:遵从“平衡序贯法”分组,将我市妇幼保健医院作为调查对象,调查2019.1-2020.4内的49例小儿肺炎合并心力衰竭患儿分为对照组(25例,常规护理)和观察组(24例,个体化护理),观察干预效果。结果:观察组干预效果较好,心功能改善较显著,数据和对照组相比,P<0.05。结论:对小儿肺炎合并心力衰竭患儿开展临床护理,建议采纳个体化护理模式,可有效提高应用效果并改善心功能。
莹 鲍, 荣荣 延, 微 王
semanticscholar +1 more source
目的探讨外周血白细胞端粒长度与慢性心力衰竭(CHF)发生风险的相关性。方法本研究招募了224例患者,根据左心室射血分数分为非CHF(Non-CHF)组(117例)和CHF组(107例),用实时荧光定量多聚核苷酸链式反应( qPCR) 进行外周血白细胞端粒长度的测量。比较Non-CHF组和CHF组患者端粒长度,并采用二元 Logistic回归模型分析端粒长度与CHF发生风险是否相关。结果Non-CHF组和CHF组患者外周血白细胞端粒相对长度分别为0.9(0.64~1.18)、0.7(0.53~0.89 ...
吴智业 +5 more
core +1 more source
Interpretation of the 2015 guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism by the European Thyroid Association [PDF]
亚临床甲状腺功能亢进症在临床中很常见,但对其危害及处理有很大的争议。欧洲甲状腺学会根据现有的临床证据,公布了内因性亚临床甲状腺功能亢进症诊治指南; 。指南强调,要确立持续性亚临床甲状腺功能亢进症的诊断,明确其病因,按照其进展为临床甲亢、发生不良心血管事件及骨质疏松风险进行危险分层,以指导临床; 处理。Endogenous subclinical hyperthyroidism (Endo SHyper) is a common form of; thyroid diseases.
刘超, 李学军, 肖方森
core +1 more source
Abstract Aims To examine the association between nurse skill mix (the proportion of total hours provided by Registered Nurses) and patient outcomes in acute care hospitals. Design A quantitative systematic review included studies published in English between January 2000 – September 2018.
Diane E. Twigg +3 more
wiley +1 more source
Characteristics and Prognosis of Herat Failure with Improved Ejection Fraction [PDF]
BackgroundLeft ventricular ejection fraction (LVEF) is often used to classify heart failure (HF) . Some HF patients were observed to have improved ejection fraction after treatment, thus giving rise to the concept of HF with improved EF (HFimpEF ...
SU Kangkang, WANG Yan, WANG Lili, CHEN Shuxia, GU Jian
core +1 more source

